07/20/2017 - 2:06pm

Gilead’s hepatitis C treatment Vosevi and Puma Biotechnology’s breast cancer drug Nerlynx both earned Food and Drug Administration approval this week. 

07/17/2017 - 4:31pm

CVS Health president and CEO Larry Merlo made the announcement alongside Rhode Island Gov. Gina Raimondo at the 2017 National Governor’s Association Summer Meeting, where Merlo has been touting the company’s approach to providing accessible and effective care.

07/14/2017 - 11:35am

Tremfya (guselkumab) is the first drug to be approved that selectively blocks a key plaque psoriasis cytokine, the company said.

07/14/2017 - 11:23am

Mike Hotra joins the organization as VP of its public affairs team, and Ken McKay is the advocacy organization’s new VP state government affairs. 

07/10/2017 - 3:57pm

Endari (L-glutamine oral powder) was developed and is manufactured by Emmaus Life Sciences.

07/10/2017 - 3:09pm

The program would restore access to chain and independent pharmacies for TRICARE beneficiaries, who currently have to obtain non-generic medications through mail-order pharmacies or military treatment facilities.

07/05/2017 - 1:44pm

Advent International is buying the Mexican private generics leader from Endo for roughly $124 million. 

06/30/2017 - 1:16pm

Along with the new indication, the Food and Drug Administration DA approved a next-generation sequencing-based test to identify the RAS mutation status of a patient’s tumor, which Amgen said helps identify patients who would benefit from treatment with Vectibix. 

06/29/2017 - 4:21pm

The agency has outlined its Orphan Drug Modernization plan, which it said is part of a larger effort called the Medical Innovation Development plan modernize and make efficient the FDA’s regulatory tools and policies.